Brainomix on Thursday shared results from a study indicating that its AI imaging platform can objectively measure the efficacy of Argenica Therapeutics' neuroprotective peptide ARG-007 u...

Natera announced on Thursday the publication of a post-hoc analysis demonstrating that its Signatera circulating tumour DNA (ctDNA) test can accurately identify whether patients with sta...

BlueWind Medical announced Tuesday that its enhanced Revi system has received FDA 510(k) clearance for the long-term treatment of urgency urinary incontinence (UUI). Re...

As part of its rebrand for what it calls "the GLP-1 era," WeightWatchers on Tuesday unveiled an integrated platform designed to support patients taking weight-loss medications, combining...

Noom launched a new GLP-1 programme on Monday called Proactive Health Microdose ...

Exact Sciences presented data at the San Antonio Breast Cancer Symposium (SABCS) showing that its Oncodetect molecular residual disease (MRD) test reliably predicted distant recurrence i...

The FDA has cleared Flow Neuroscience's at-home brain stimulation device for the treatment of major depressive disorder (MDD). The authorisation makes Flow FL-100 the first non-drug ther...

Illumina announced Thursday a collaboration and strategic investment in MyOme, a whole genome analysis platform, to support MyOme's Proactive Health Trial. The trial aims to show how pai...

Vektor Medical announced Wednesday that it has received FDA 510(k) clearance for the latest version of its vMap technology, an AI-enabled platform that uses standard 12-lead electrocardi...

NeuroPace on Monday shared preliminary findings from its ongoing NAUTILUS trial evaluating adjunctive neuromodulation in patients with idiopathic generalised epilepsy (IGE) resistant to ...

Resmed has received FDA clearance for Smart Comfort, an AI-driven feature that enables users of continuous positive airway pressure (CPAP) to personalise therapy. Smart Comfort joins Res...

The FDA has announced a new digital health pilot, called TEMPO, that will run within the Centres for Medicare and Medicaid Services (CMS)

The US Department of Health and Human Services (HHS) unveiled on Thursday its "OneHHS" strategy to integrate AI across all agencies, including the Centers for Disease Control and Prevent...

LabGenius Therapeutics announced Thursday its second collaboration with Sanofi to use AI and machine learning to optimise therapeutic NANOBODY molecules and improve their most clinically...

Google announced new health AI funding at the European Health Summit in Brusse...

Agentic AI tools are still far from routine clinical use as doctors demand stronger evidence and highe...

Roche on Tuesday announced that its point-of-care test for diagnosing Bordatella...

The FDA announced on Monday that it has launched agentic AI capabilities for its staff as part of its ...

Researchers from the University of California, Los Angeles (UCLA) have investigated whether commercially-available ambient AI scribes can help reduce physician documentation burden and b...

GE HealthCare has received FDA premarket authorisation for Pristina Recon DL, its AI-powered 3D mammography reconstruction application.An upgrade to the Pristina Via sy...